Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia.

Archives of gynecology and obstetrics - 1 Jun 2024

Shome Durjoy, Al-Jamea Lamiaa, Woodman Alexander, Salem Abdel Halim, Bakhiet Moiz, Taha Safa, Sandhu Amarjit Kaur, Al-Yami Fatimah S, Waheed Khawaja Bilal, Elnagi Elmoeiz Ali, Almish Mohammed, Quiambao Jenifer Vecina

Abstract excerpt

PURPOSE: This is the first study that aimed to determine antigen levels in plasma and genotypes of PAI-2 in pregnant and non-pregnant homozygous sickle cell anemia (SCA) patients. METHODS: The study subjects were all Bahraini females in the reproductive age group. The study population included 31 pregnant homozygous SS (SCA) patients. Three control groups were also studied to evaluate the effect of pregnancy and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibrinolysis

Share to Genotype

Share to Pregnancy

Share to Pregnancy Complications, Hematologic

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 37401942
DOI: 10.1007/s00404-023-07121-6
PMCID: PMC11147938

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia.PMID 37401942Read ↗

Pregnancy‐related thromboembolism in women with sickle cell disease: An analysis of National Medicaid DataSemantic proximity Read ↗

Pregnancy in the Sickle Cell Disease and Fetomaternal Outcomes in Different Sickle cell Genotypes: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Sickle cell disease and pregnancy.Semantic proximity Read ↗

Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gapsSemantic proximity Read ↗

Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies.Semantic proximity Read ↗

Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy.Semantic proximity Read ↗

Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.Semantic proximity Read ↗

Profile of Reproductive Issues Associated with Different Sickle Cell Disease Genotypes.Semantic proximity Read ↗

Pregnancy and Sickle Cell DiseaseSemantic proximity Read ↗

Serum levels of angiogenic factors indicate a pro‐angiogenic state in adults with sickle cell diseaseSemantic proximity Read ↗

[Sickle cell anemia and pregnancy: review of 68 cases in Guadeloupe].Semantic proximity Read ↗

Plasma/serum protein patterns in human fetuses and infants: a study by high-resolution two-dimensional polyacrylamide gel electrophoresis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.